Medical Equipment

Pharmaxis Ltd (ASX:PXS) Boehringer Ingelheim is Initiating Phase IIa Study for the Development of a New Treatment for Diabetic Retinopathy - a Leading Cause of Vision-Loss

🕔9/8/2017 1:38:29 PM

Boehringer Ingelheim and pharmaceutical research company Pharmaxis (ASX:PXS) (OTCMKTS:PXSLY) announce that Boehringer Ingelheim is initiating the Phase IIa study ROBIN. This marks the beginning of the clinical development program for BI 1467335 in a second indication targeting a severe diabetes complication. An already ongoing Phase II clinical study program is investigating the compound in NASH.

Read Full Article

Boehringer Ingelheim Initiates Phase IIa Study of Compound Acquired from Pharmaxis Ltd (ASX:PXS) in Debilitating Liver Disease NASH

🕔9/8/2017 12:01:53 PM

Boehringer Ingelheim and pharmaceutical company Pharmaxis (ASX:PXS) (OTCMKTS:PXSLY) announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial in NASH with BI 1467335 (formerly known as PXS-4728A), acquired from Pharmaxis in May 2015.

Read Full Article

Traditional Therapy Clinics Ltd (ASX:TTC) Acquiring Five Greenfield Clinics and Three Franchise Clinics

🕔9/1/2017 11:40:34 AM

Traditional Therapy Clinics Limited (ASX:TTC) is pleased to advise that the Company is making significant progress on building its first series of greenfield clinics. There are five greenfield clinics being established whereby three of them are located in Guizhou, one in Hanan and one in Inner Mongolia.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Audited Financial Statements and Appendix 4E

🕔8/31/2017 1:27:22 PM

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to release its Appendix 4E with its full year audited general purpose financial report for the period ending 30 June 2017.

Read Full Article

Traditional Therapy Clinics Ltd (ASX:TTC) Appendix 4D and Interim Financial Report

🕔8/30/2017 11:59:14 AM

The Directors present their report, together with the financial statements, on the consolidated entity consisting of Traditional Therapy Clinics Limited (ASX:TTC) and the entities it controlled at the end of, or during, the half-year ended 30 June 2017.

Read Full Article

FINANCE VIDEO: Oventus Medical Ltd (ASX:OVN) Financial News Network Interview

🕔8/24/2017 10:00:45 AM

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to share Dr Chris Hart's interview on Financial News Network.

Read Full Article

Traditional Therapy Clinics Ltd (ASX:TTC) Completion of Share Placement and Cleansing Notice

🕔8/11/2017 9:23:14 AM

Traditional Therapy Clinics Ltd (ASX:TTC) is pleased to announce the successful completion of the placement to sophisticated investors today to place a total of 5,700,000 ordinary shares in the Company for a total amount of $1,995,000 at a price of $0.35 per share.

Read Full Article